因自伤至急诊就诊者中家庭暴力的患病率及相关因素:来自区域自伤登记的数据
该横断面研究利用英国一个区域自伤登记处数据,纳入因自伤至急诊就诊者1142例,测量家庭暴力(DV)的患病率及相关因素。结果显示11.1%(95%CI 9.4%–13.1%)报告DV;报告DV者更可能为女性、与伴侣分居,DV与自服毒物自伤及既往自伤发生相关。作者认为,因自伤至急诊就诊者中DV受害率高于一般急诊就诊人群,DV的存在可能提示该人群风险增加。
要点
- 因自伤至急诊就诊者中,11.1%(95%CI 9.4%–13.1%)报告家庭暴力。
- 报告家庭暴力者更可能为女性、与伴侣分居。
- 家庭暴力与自服毒物自伤及既往自伤发生相关。
- 作者认为,家庭暴力受害在因自伤至急诊就诊者中比一般急诊就诊人群更常见,DV的存在可能提示风险增加。
适用人群与场景
- 英国因自伤至急诊就诊并纳入区域自伤登记的患者(n=1142)。
研究设计与关键结果
- 研究类型为横断面研究,使用区域自伤登记数据,纳入因自伤至急诊就诊者1142例。
- 11.1%(95% CI 9.4% to 13.1%)的样本报告家庭暴力。
- 报告家庭暴力者更可能为女性、与伴侣分居;家庭暴力与自服毒物自伤及既往自伤发生相关。
证据类型、等级与局限
- 证据类型:横断面研究,使用登记数据。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,家庭暴力受害在因自伤至急诊就诊者中比一般急诊就诊人群更常见,DV的存在可能提示该人群风险增加。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Previous research suggests that there is an association between domestic violence (DV) and self-harm (SH). Yet, the prevalence and clinical significance of DV among individuals presenting acutely to hospital with SH in the UK is unknown.
OBJECTIVE: To measure the prevalence and correlates of DV among patients presenting to hospital with SH.
METHODS: We conducted a cross-sectional study using registry data in order to describe the prevalence of DV within a UK population of people presenting to the emergency department (ED) with SH (n=1142).
RESULTS: 11.1% (95% CI 9.4% to 13.1%) of the sample reported DV. Those reporting DV were more likely to be female and separated from a partner. DV was associated with self-poisoning and with previous occurrence of SH.
CONCLUSION: Our findings suggest that DV victimisation is more prevalent among those presenting to ED with self-harm than among the general population of ED attenders, and that the presence of DV may signify increased risk among those presenting to ED with SH.
参考来源
- Dalton TR, Knipe D, Feder G, et al. Prevalence and correlates of domestic violence among people seeking treatment for self-harm: data from a regional self-harm register. Emerg Med J. 2019. PMID: 31239314. doi:10.1136/emermed-2018-207561
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。